Teclistamab therapy shows potential in achieving drug-free remission in patients with refractory autoimmune diseases, with manageable cytokine release syndrome.

Non-adherence to at least one prescribed antidiabetic drug is highly common among patients with type 2 diabetes and rises ...

The presence of frailty prior to dialysis and changes in frailty status during the first 6 months of dialysis can predict the ...

Insights from AAO 2025, including anticipated presentations, key takeaways, and how emerging research on non-AMD retinal ...

Dr Sunir Garg looks ahead to presentations on new developments in retinal eye disease treatments, medication risks, and updated screening guidelines.

Thousands of patients have presented to emergency departments with ocular injuries sustained while playing the increasingly ...

About 1 in 5 physicians said in a Medscape survey they pondered a switch to a nonclinical career. Of those, around half ...

A secondary analysis of TRAILBLAZER-ALZ 2 strengthens the case that reducing amyloid plaques underlies the clinical benefits ...

Open-label or ‘honest’ placebos are linked to reduced pain-related disability and may have a supportive role in migraine care ...

Primary headaches are linked to increased risk for depression in both men and women, while tension headache is linked to ...

About 90% of people in the Lower Mainland of British Columbia have detectable antibodies against measles, indicating robust ...

Despite setbacks and funding cuts — and a quieting of the hype blaring its arrival — multiple CRISPR-based trials are ...